6533b836fe1ef96bd12a13dc
RESEARCH PRODUCT
Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and C-reactive protein levels and metabolic status in patients with a bipolar disorder
Gemma SafontL MarínP. SierraAna Garcia-blancoL. De La FuenteM.p. García-portillaBelén ArranzMarina GarrigaMónica Sanchez-autetsubject
medicine.medical_specialtyBipolar DisorderNeutrophilsLymphocyteInflammationGastroenterologyInsulin resistanceInternal medicinemedicineHumansLymphocytesBipolar disorderBiological PsychiatryRetrospective StudiesMetabolic SyndromebiologyPlatelet Countbusiness.industryC-reactive proteinQuantitative insulin sensitivity check indexmedicine.diseasePsychiatry and Mental healthC-Reactive Proteinmedicine.anatomical_structurebiology.proteinHomeostatic model assessmentInsulin ResistanceMetabolic syndromemedicine.symptombusinessBiomarkersdescription
OBJECTIVES Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and C-Reactive Protein (CRP) are markers of inflammation that are elevated in bipolar disorder (BD) and are also related to a higher risk of metabolic syndrome (MetS). This study aimed at investigating for the first time the association between NLR, PLR, and CRP and the metabolic status in BD. METHODS We assessed the association between biomarkers and the metabolic status: number of metabolic risk factors, presence of MetS, insulin sensitivity (Quantitative Insulin Sensitivity Check Index, QUICKI) and insulin resistance (Homeostatic Model Assessment for Insulin Resistance, HOMA-IR index), in a sample of 219 outpatients with BD. RESULTS 25.9% of the sample met the criteria for MetS. High levels of CRP were found in 12% of the sample. Older age, low PLR, high NLR, and high CRP levels significantly predicted a higher number of MetS risk factors (p < 0.001). Older age and low PLR were associated with a greater likelihood of developing MetS (p = 0.007). CONCLUSIONS Although further studies are needed to replicate and validate these findings, inflammatory biomarkers as CRP, PLR and NLR could be useful tools to identify patients with a BD at risk for a metabolic adverse outcome.
year | journal | country | edition | language |
---|---|---|---|---|
2022-01-12 | The World Journal of Biological Psychiatry |